Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)

Liver Transplantation and Surgery

Volumn 3, Issue 1, 1997, Pages 1-9

  Canzanello, V J ^a   Schwartz, L ^a   Taler, S J ^a   Textor, S C ^a   Wiesner, R H ^a   Porayko, M K ^a   Krom, R A F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 0031030538     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500030101     Document Type: Article

References (41)